25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use ... Once injected, it forms a gel under the ...
RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.
Some in the legislature are now pushing Senate Bill 480, which would weaken prior authorization in Indiana. If that happens, ...
News-Medical.Net on MSN4d
Restricting telehealth prescriptions for opioid use disorder could undermine recoveryWeill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could keep thousands from accessing buprenorphine, a medication that helps people recover ...
What you need to know about opioid overdose reversal drug nalmefene’s risks, effectiveness and clinical concerns ...
Academic cites challenges of addiction after Monash University finds many injured workers receiving 'high-risk' prescriptions ...
The analysis of health insurance claims data from almost 3 million U.S. patients investigated prescribed stimulants' impact on prescription opioid use over 10 years, looking for origins of the so ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback